STATINS AND THE RISK OF DIABETES MELLITUS
Randomized controlled trials have clearly demonstrated the efficacy of statins in reduction of serum low density lipoprotein cholesterol level by 25-50% from the baseline. Statins may increase the risk of diabetes mellitus (DM) in long-term therapy and use of high doses. Diabetogenic action is stati...
| Κύριος συγγραφέας: | |
|---|---|
| Μορφή: | Άρθρο |
| Γλώσσα: | English |
| Έκδοση: |
Столичная издательская компания
2015-09-01
|
| Σειρά: | Рациональная фармакотерапия в кардиологии |
| Θέματα: | |
| Διαθέσιμο Online: | http://www.rpcardio.ru/jour/article/view/111 |